India to Tajikistan: Ceftazidime Export Trade Route
India has recorded 23 verified shipments of Ceftazidime exported to Tajikistan, representing a combined trade value of $330.0K USD. This corridor is served by 14 active Indian exporters, with an average shipment value of $14.3K USD. The leading Indian exporter is EVOLET HEALTHCARE PRIVATE LIMITED, which accounts for 42% of total export value with 5 shipments worth $138.9K USD. On the buying side, ASIAPHARM LLC. is the largest importer in Tajikistan with $77.7K USD in purchases. The top 3 suppliers — EVOLET HEALTHCARE PRIVATE LIMITED, SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI , EVOLET HEALTHCARE PRIVATE LIMITED — together control 66% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Tajikistan Ceftazidime corridor is one of India's established pharmaceutical export routes, with 23 shipments documented worth a combined $330.0K USD. The route is dominated by EVOLET HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 42% of all export value, reflecting the consolidated nature of India's ceftazidime manufacturing sector.
Across 14 active suppliers, the average shipment value stands at $14.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with ceftazidime's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 19.2%, placing it at rank #5 among India's top ceftazidime export destinations globally.
On the import side, key buyers of Indian ceftazidime in Tajikistan include ASIAPHARM LLC., LLC "IMRON 2020" , MADAD PHARMA LLC and 14 others. ASIAPHARM LLC. is the single largest importer with 3 shipments valued at $77.7K USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ1
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#5
- Annual growth+19.2%
- Demand growth+18.2%
- Regulatory ease76/100
Top 10 Indian Ceftazidime Exporters to Tajikistan
Showing top 10 of 14 Indian suppliers exporting Ceftazidime to Tajikistan, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVOLET HEALTHCARE PRIVATE LIMITED Avg $27.8K per shipment | 5 | $138.9K | 42.1% |
| 2 | SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI Avg $24.6K per shipment | 2 | $49.2K | 14.9% |
| 3 | EVOLET HEALTHCARE PRIVATE LIMITED Avg $29.6K per shipment | 1 | $29.6K | 9.0% |
| 4 | VENUS INTERNATIONAL Avg $18.7K per shipment | 1 | $18.7K | 5.7% |
| 5 | HEAL REMEDICS PRIVATE LIMITED Avg $8.6K per shipment | 2 | $17.3K | 5.2% |
| 6 | AQUARIUS ENTERPRISES Avg $13.7K per shipment | 1 | $13.7K | 4.1% |
| 7 | IND SWIFT LIMITED Avg $13.0K per shipment | 1 | $13.0K | 4.0% |
| 8 | K.R.PHARMA Avg $5.9K per shipment | 2 | $11.7K | 3.6% |
| 9 | procpicio global Avg $3.1K per shipment | 3 | $9.4K | 2.8% |
| 10 | SKYMAP PHARMACEUTICALS PRIVATE LIMITED Avg $8.5K per shipment | 1 | $8.5K | 2.6% |
This table shows the top 10 of 14 Indian companies exporting ceftazidime to Tajikistan, ranked by total trade value. The listed exporters are: EVOLET HEALTHCARE PRIVATE LIMITED, SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI , EVOLET HEALTHCARE PRIVATE LIMITED , VENUS INTERNATIONAL, HEAL REMEDICS PRIVATE LIMITED, AQUARIUS ENTERPRISES, IND SWIFT LIMITED , K.R.PHARMA, procpicio global, SKYMAP PHARMACEUTICALS PRIVATE LIMITED. EVOLET HEALTHCARE PRIVATE LIMITED is the dominant supplier with 5 shipments worth $138.9K USD, giving it a 42% market share. The top 3 suppliers together account for 66% of the total trade value on this route.
Showing top 10 of 14 total Indian exporters on the India to Tajikistan Ceftazidime export route.
Top 10 Ceftazidime Importers in Tajikistan
Showing top 10 of 17 known buyers in Tajikistan receiving Ceftazidime shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ceftazidime in Tajikistan include ASIAPHARM LLC., LLC "IMRON 2020" , MADAD PHARMA LLC, ASIAPHARM LLC , MADAD PHARM LLC, among 17 total buyers. The largest importer is ASIAPHARM LLC., accounting for $77.7K USD across 3 shipments — representing 24% of all ceftazidime imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ASIAPHARM LLC. | 3 | $77.7K | 23.6% |
| 2 | LLC "IMRON 2020" | 2 | $49.2K | 14.9% |
| 3 | MADAD PHARMA LLC | 1 | $34.4K | 10.4% |
| 4 | ASIAPHARM LLC | 1 | $29.6K | 9.0% |
| 5 | MADAD PHARM LLC | 1 | $26.7K | 8.1% |
| 6 | LLC NURI DAVO | 1 | $18.7K | 5.7% |
| 7 | TO THE ORDER OF | 1 | $13.7K | 4.1% |
| 8 | LLC TIBBI OMEXTA | 1 | $13.0K | 4.0% |
| 9 | M/S LLC HAMADON FARMA | 2 | $11.7K | 3.6% |
| 10 | LLC SHIFOI SINO N MAKHSUM | 1 | $11.2K | 3.4% |
Showing top 10 of 17 Ceftazidime importers in Tajikistan on this route.
Top 10 Ceftazidime Formulations Imported by Tajikistan
Showing top 10 of 21 product formulations shipped on the India to Tajikistan Ceftazidime route, ranked by trade value
Tajikistan imports a wide range of ceftazidime formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CEFTAZIDIME FOR INJECTION 1000MG BATCH N — accounts for $49.2K USD across 2 shipments. There are 21 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CEFTAZIDIME FOR INJECTION 1000MG BATCH N | 2 | $49.2K | 14.9% |
| 2 | CEFTAZIDIME VIAL 1000 MG/20 ML #1 -BATCH# E1175 MFG D- 03/03/2025 & EXP D- 02/03/2028 | 1 | $40.4K | 12.2% |
| 3 | CEFTAZIDIME VIAL 1000 MG/20 ML #1 - MFGD- 02/2024 EXP D- 07/2026 BATCH NO- AVX4001, AVX4002 | 1 | $34.4K | 10.4% |
| 4 | Ceftazidime vial 1000 mg/20 ml #1 BATCH | 1 | $29.6K | 9.0% |
| 5 | Ceftazidime vial 1000 mg/20 ml #1 BATCH | 1 | $27.5K | 8.3% |
| 6 | PHARMACEUTICALS PRODUCT CEFTAZIDIME VIAL1000 MG/20 ML #1 BATCH NO.E793 MANUFACTURING . DATE 19/09/2023 E/DT 18/09/2026 | 1 | $26.7K | 8.1% |
| 7 | PHARMACEUTICAL GOODS TAZOMIN 1 0GINJECTION Ceftazidime For Injection USP 1 gm 10 x 1 x 1vial | 1 | $18.7K | 5.7% |
| 8 | HEALZIM (CEFTAZIDIME 1.0G POWDER FOR INJECTION) | 1 | $13.7K | 4.1% |
| 9 | SWIFTZIDIME 1GM(CEFTAZIDIME 1000MG)1X20M | 1 | $13.0K | 4.0% |
| 10 | ELCOZIDIME 1GM CEFTAZIDIME 1GM 20ML VIALQTY CONT & OTHER ETC AS PER INV | 1 | $11.2K | 3.4% |
Showing top 10 of 21 Ceftazidime formulations imported by Tajikistan on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 5 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's ceftazidime exports to Tajikistan are driven primarily by a handful of large-scale manufacturers. EVOLET HEALTHCARE PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in Tajikistan benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EVOLET HEALTHCARE PRIVATE LIMITED, SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI , EVOLET HEALTHCARE PRIVATE LIMITED — together account for 66% of total trade value on this route. The average shipment value of $14.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as ceftazidime vial 1000 mg/20 ml #1 -batch# e1175 mfg d- 03/03/2025 & exp d- 02/03/2028 and ceftazidime vial 1000 mg/20 ml #1 - mfgd- 02/2024 exp d- 07/2026 batch no- avx4001, avx4002, suggesting that buyers in Tajikistan tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ASIAPHARM LLC. is the largest importer with 3 shipments worth $77.7K USD — representing 24% of all ceftazidime imports from India on this route. A total of 17 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $330.0K
- Avg. Shipment
- $14.3K
- Suppliers
- 14
- Buyers
- 17
- Transit (Sea)
- ~15 days
- Annual Growth
- +19.2%
Related Analysis
Other Ceftazidime Routes
Unlock the Full India to Tajikistan Ceftazidime Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 23 shipments on this route.
Frequently Asked Questions — India to Tajikistan Ceftazidime Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ceftazidime to Tajikistan?
The leading Indian exporters of Ceftazidime to Tajikistan are EVOLET HEALTHCARE PRIVATE LIMITED, SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI , EVOLET HEALTHCARE PRIVATE LIMITED . EVOLET HEALTHCARE PRIVATE LIMITED holds the largest market share at approximately 42% of total trade value on this route.
Q What is the total value of Ceftazidime exports from India to Tajikistan?
India exports Ceftazidime to Tajikistan worth approximately $330.0K USD across 23 recorded shipments. The average value per shipment is $14.3K USD.
Q Which ports does India use to ship Ceftazidime to Tajikistan?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 5 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 22% by air.
Q How long does shipping take from India to Tajikistan for Ceftazidime?
The average transit time for Ceftazidime shipments from India to Tajikistan is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Tajikistan Ceftazidime trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 19.2% with demand growth tracking at 18.2%. The route is ranked #5 among India's top Ceftazidime export destinations globally.
Q How many suppliers are active on the India to Tajikistan Ceftazidime route?
There are currently 14 active Indian suppliers exporting Ceftazidime to Tajikistan. The market is moderately concentrated with EVOLET HEALTHCARE PRIVATE LIMITED accounting for 42% of total shipment value.
Q Who are the main importers of Ceftazidime from India in Tajikistan?
The leading importers of Indian Ceftazidime in Tajikistan include ASIAPHARM LLC., LLC "IMRON 2020" , MADAD PHARMA LLC, ASIAPHARM LLC , MADAD PHARM LLC. ASIAPHARM LLC. is the largest buyer with 3 shipments worth $77.7K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Tajikistan export trade corridor identified from Indian Customs (DGFT) records for Ceftazidime.
- 2.Supplier/Buyer Matching: 14 Indian exporters and 17 importers in Tajikistan matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 23 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
23 Verified Shipments
14 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists